Breast Cancer Clinical Trials

Showing 2681-2700 of 5,597 trials

Neoadjuvant Endocrine Therapy in Breast Cancer. Real Clinical Practice in Russia

NCT05800197

Neoadjuvant Endocrine Therapy for pre- and postmenopausal women with T4 Nany or TanyN2-3 estrogen receptor (ER) -positive, progrsteron receptor (PR) -positive and HER2 negative breast cancer. Real Clinical Practice in Russia.

Breast CancerNeoadjuvant Endocrine Therapy

Blokhin's Russian Cancer Research Center300 participantsStarted Apr 2014

Moscow, Russia

COMPLETEDPhase 3

Phase III to Evaluate Patient´s Preference of Subcutaneous Trastuzumab vs Intravenous in HER2+ Advanced Breast Cancer

NCT01875367

GEICAM/2012-07 is a study phase III, prospective, open, randomized, multicenter and national designed to assess patient preference for intravenous (IV) or subcutaneous (SC) of trastuzumab, and within the SC by the administration through the vial or device self-administration in patients with disseminated breast cancer HER2.

Breast Cancer

Spanish Breast Cancer Research Group166 participantsStarted Sep 2013

Manacor, Balearic Islands, Spain • Granollers, Barcelona, Spain • Mataró, Barcelona, Spain +24 more locations

Neoadjuvant Endocrine Therapy in Breast Cancer. Real Clinical Practice in Russia

Phase III to Evaluate Patient´s Preference of Subcutaneous Trastuzumab vs Intravenous in HER2+ Advanced Breast Cancer

Related Searches

Caelyx, Cyclophosphamide and Herceptin in Patients With Metastatic Breast Cancer

Optical Spectroscopy in Evaluating Tumor Margins in Patients Who Have Undergone Surgery for Breast Tumors

Automated Breast Ultrasound Screening

Epidemiology of Breast Cancer in Women Based on Diagnosis Data From Oncologists and Breast Surgeons in Algeria

Automated Low Dose Risk Assessment Mammography (ALDRAM)

Selective Neoadjuvant Treatment According to Immunohistochemical Subtype for HER2 Negative Breast Cancer Patients

Trial to Evaluate Efficacy and Safety of Pembrolizumab and Gemcitabine in HER2-negative ABC

Effects o Laughing Qigong Program on Psychological Outcomes and the Physiological Immunological Responses

Patterns of Prescribing and Monitoring of Palbociclib

EC Followed Docetaxel Versus ET Followed Capecitabine as Adjuvant Chemotherapy for Node Positive Operable Breast Cancer

A Phase Ⅰb/Ⅱ Clinical Study of SHR-A1811 Combined With Other Therapies in Patients With HER2 Low Advanced or Metastatic Breast Cancer.

Study to Evaluate the Feasibility of 13-C Pyruvate Imaging in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors

Clinical Evaluation of Opto-Acoustic Image Quality With the Gen 2 Imagio System

Effectiveness and Safety Study of Filgrastine® in Patientes With Breast Cancer Treated With Myelotoxic Chemotherapy

Gemcitabine +/- Imatinib Mesylate, Patients w/Previously Treated Metastatic Breast Cancer

Genetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast Cancer

Co'Moon for Supporting Breast Cancer Patients on Adjuvant Endocrine Therapy